PMC:7361216 / 4440-4591 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T56","span":{"begin":15,"end":18},"obj":"Body_part"},{"id":"T57","span":{"begin":87,"end":90},"obj":"Body_part"},{"id":"T58","span":{"begin":91,"end":99},"obj":"Body_part"},{"id":"T59","span":{"begin":134,"end":139},"obj":"Body_part"}],"attributes":[{"id":"A56","pred":"fma_id","subj":"T56","obj":"http://purl.org/sig/ont/fma/fma62873"},{"id":"A57","pred":"fma_id","subj":"T57","obj":"http://purl.org/sig/ont/fma/fma62873"},{"id":"A58","pred":"fma_id","subj":"T58","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A59","pred":"fma_id","subj":"T59","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"ring from this IgM monoclonal gammopathy, non‐specific strategies are used to diminish IgM antibody including targeting of all CD20 B cells with Rituxi"}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T12","span":{"begin":19,"end":40},"obj":"Disease"}],"attributes":[{"id":"A12","pred":"mondo_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/MONDO_0004960"}],"text":"ring from this IgM monoclonal gammopathy, non‐specific strategies are used to diminish IgM antibody including targeting of all CD20 B cells with Rituxi"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T65","span":{"begin":132,"end":139},"obj":"http://purl.obolibrary.org/obo/CL_0000236"}],"text":"ring from this IgM monoclonal gammopathy, non‐specific strategies are used to diminish IgM antibody including targeting of all CD20 B cells with Rituxi"}

    LitCovid-sample-PD-IDO

    {"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T17","span":{"begin":134,"end":139},"obj":"http://purl.obolibrary.org/obo/CL_0000000"}],"text":"ring from this IgM monoclonal gammopathy, non‐specific strategies are used to diminish IgM antibody including targeting of all CD20 B cells with Rituxi"}

    LitCovid-sample-UniProt

    {"project":"LitCovid-sample-UniProt","denotations":[{"id":"T50","span":{"begin":127,"end":131},"obj":"Protein"}],"attributes":[{"id":"A50","pred":"uniprot_id","subj":"T50","obj":"https://www.uniprot.org/uniprot/Q3C2E2"},{"id":"A51","pred":"uniprot_id","subj":"T50","obj":"https://www.uniprot.org/uniprot/Q13963"},{"id":"A52","pred":"uniprot_id","subj":"T50","obj":"https://www.uniprot.org/uniprot/P19437"},{"id":"A53","pred":"uniprot_id","subj":"T50","obj":"https://www.uniprot.org/uniprot/P11836"},{"id":"A54","pred":"uniprot_id","subj":"T50","obj":"https://www.uniprot.org/uniprot/P08984"},{"id":"A55","pred":"uniprot_id","subj":"T50","obj":"https://www.uniprot.org/uniprot/B4DT24"},{"id":"A56","pred":"uniprot_id","subj":"T50","obj":"https://www.uniprot.org/uniprot/A6NMS4"}],"text":"ring from this IgM monoclonal gammopathy, non‐specific strategies are used to diminish IgM antibody including targeting of all CD20 B cells with Rituxi"}

    LitCovid-sample-PD-FMA

    {"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T56","span":{"begin":15,"end":18},"obj":"Body_part"},{"id":"T57","span":{"begin":87,"end":90},"obj":"Body_part"},{"id":"T58","span":{"begin":91,"end":99},"obj":"Body_part"},{"id":"T59","span":{"begin":134,"end":139},"obj":"Body_part"}],"attributes":[{"id":"A59","pred":"fma_id","subj":"T59","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A57","pred":"fma_id","subj":"T57","obj":"http://purl.org/sig/ont/fma/fma62873"},{"id":"A58","pred":"fma_id","subj":"T58","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A56","pred":"fma_id","subj":"T56","obj":"http://purl.org/sig/ont/fma/fma62873"}],"text":"ring from this IgM monoclonal gammopathy, non‐specific strategies are used to diminish IgM antibody including targeting of all CD20 B cells with Rituxi"}

    LitCovid-sample-PD-MONDO

    {"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T15","span":{"begin":19,"end":40},"obj":"Disease"}],"attributes":[{"id":"A15","pred":"mondo_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/MONDO_0004960"}],"text":"ring from this IgM monoclonal gammopathy, non‐specific strategies are used to diminish IgM antibody including targeting of all CD20 B cells with Rituxi"}